PMC:7268883 / 19387-19983 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"363","span":{"begin":499,"end":511},"obj":"Species"},{"id":"364","span":{"begin":547,"end":559},"obj":"Species"},{"id":"365","span":{"begin":387,"end":406},"obj":"Disease"}],"attributes":[{"id":"A363","pred":"tao:has_database_id","subj":"363","obj":"Tax:9606"},{"id":"A364","pred":"tao:has_database_id","subj":"364","obj":"Tax:9606"},{"id":"A365","pred":"tao:has_database_id","subj":"365","obj":"MESH:D010182"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T175","span":{"begin":387,"end":406},"obj":"Disease"}],"attributes":[{"id":"A175","pred":"mondo_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/MONDO_0002356"}],"text":"The strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T62","span":{"begin":77,"end":78},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T63","span":{"begin":416,"end":417},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T64","span":{"begin":533,"end":534},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"The strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":435,"end":440},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"The strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}

{"project":"LitCovid-sentences","denotations":[{"id":"T125","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T126","span":{"begin":119,"end":191},"obj":"Sentence"},{"id":"T127","span":{"begin":192,"end":407},"obj":"Sentence"},{"id":"T128","span":{"begin":408,"end":520},"obj":"Sentence"},{"id":"T129","span":{"begin":521,"end":596},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T47","span":{"begin":387,"end":406},"obj":"Phenotype"}],"attributes":[{"id":"A47","pred":"hp_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/HP_0001732"}],"text":"The strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}